Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.
- Published In:
- Endocrine, 48(2), 461-71 (2015)
- Authors:
- Giorda, Carlo B, Sacerdote, Carlotta, Nada, Elisa, Marafetti, Lisa, Baldi, Ileana, Gnavi, Roberto
- Database ID:
- RPEP-02648
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02648APA
Giorda, Carlo B; Sacerdote, Carlotta; Nada, Elisa; Marafetti, Lisa; Baldi, Ileana; Gnavi, Roberto. (2015). Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.. Endocrine, 48(2), 461-71. https://doi.org/10.1007/s12020-014-0386-8
MLA
Giorda, Carlo B, et al. "Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.." Endocrine, 2015. https://doi.org/10.1007/s12020-014-0386-8
RethinkPeptides
RethinkPeptides Research Database. "Incretin-based therapies and acute pancreatitis risk: a syst..." RPEP-02648. Retrieved from https://rethinkpeptides.com/research/giorda-2015-incretinbased-therapies-and-acute
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.